22nd Annual Van Der Meulen Symposium: Dementia Update

Non-Profit
U.S. Postage
PAID
University
of Southern
California
22nd Annual
Van Der Meulen Symposium:
Dementia Update
Aresty Conference Center on the
USC Health Sciences Campus
Los Angeles, CA 90033
7:00 am-3:00 pm
May 16, 2015
22nd Annual Van Der Meulen Symposium:
Dementia Update
Office of Continuing Medical Education
1540 Alcazar Street, CHP 223
Los Angeles, CA 90033
Saturday
May 16, 2015
Aresty Conference Center on
USC Health Sciences Campus
1450 Biggy Street
Los Angeles, California 90033
Presented by:
The USC Alzheimer Disease Research Center
USC Off ice of Continuing Medical Education
PROGRAM
7:00 am
8:00 am
Registration and Continental Breakfast
Welcome
Helena Chui, M.D.
Morning Session: Evidence-Based Dementia Practice
Moderator: Helena Chui, M.D.
8:05 am
Epidemiology of Cognitive Impairment/Dementia
Helena Chui, M.D.
9:00 am
MRI and FDG PET Imaging
Collins Liu, M.D.
8:30 am
9:30 am
10:00 am
10:15 am
Clinical Assessment: Cognitive & Behavioral Networks
Liliana Ramirez-Gomez, M.D.
Molecular Biomarkers: CSF/PET
John Ringman, M.D.
Break
Symptomatic Treatment
Freddi Segal-Gidan, PA-C, Ph.D.
10:45 am Models of Care in the Era of the Affordable Care Act
Laura Mosqueda, M.D.
11:15 am Case Discussions
12:00 pm
Lunch
1:00 pm
Genetic Risk Factors and Novel Pathways
Daniel Geschwind, M.D., Ph.D.
Afternoon Session: Translational Research
Moderator: John Ringman, M.D.
1:40 pm
2:20 pm
3:00 pm
Does Hyperlipidemia and Diabetes Contribute to
Alzheimer Disease?
Hussein Yassine, M.D.
Clinical Trials Update: Pre-Symptomatic &
Symptomatic Treatments
Lon Schneider, M.D.
Closing Remarks/Adjourn
FACULTY
COURSE DIRECTOR
Helena Chui, M.D.
Chair, Department of Neurology
Keck School of Medicine of USC
Los Angeles, California
GUEST FACULTY
Daniel Geschwind, M.D., Ph.D.
Professor of Neurology, Psychiatry and Bio Behavioral Sciences
Director, Center for Autism Research and Treatment (CART)
David Geffen School of Medicine at UCLA
Los Angeles, California
John Ringman, M.D.
Clinical Professor of Neurology
Associate Clinical Director,
Mary S. Eaton Center for Alzheimer’s Disease Research at UCLA
David Geffen School of Medicine at UCLA
Los Angeles, California
KECK SCHOOL OF MEDICINE OF USC
Los Angeles, California
Collins Liu, M.D.
Assistant Professor of Clinical Neurology
Laura Mosqueda, M.D.
Chair, Department of Family Medicine
Professor of Clinical Family Medicine
Liliana Ramirez-Gomez, M.D.
Assistant Professor of Clinical Neurology
Lon Schneider, M.D.
Professor of Psychiatry and the Behavioral Sciences
Freddi Segal-Gidan, PA-C, Ph.D.
Assistant Professor of Clinical Neurology and
Family Medicine
Hussein Yassine, M.D.
Assistant Professor of Medicine
COURSE DESCRIPTION
The past decade has witnessed major advances in Alzheimer disease and related disorders.
The molecular profiles of many neurodegenerative disorders can be reliably identified in
the cerebrospinal fluid. A rich array of MRI and PET tools enable visualization of cognitive networks, as well as metabolic, functional, and molecular changes. Genome wide
association studies have uncovered new mutations and genetic risk factors for Alzheimer
disease, frontotemporal dementia, and Lewy body diseases, which will hopefully point to
new pathways and therapeutic targets. Vascular risk factors are said to increase the risk
of Alzheimer disease (as well as stroke), but the etiologic pathways remain controversial.
Meanwhile, we are faced with huge challenges in providing person-centered care as baby
boomers arrive at the age of risk in the era of the Affordable Care Act.
This course provides a didactic, evidence-based, review of the differential diagnosis and
treatment of the most common forms of dementia (e.g., Alzheimer disease, vascular
cognitive impairment, dementia with Lewy bodies, and fronto-temporal dementia). The
morning session focuses on dementia practice, while the afternoon session tackles exciting
translational research topics (e.g., genetics, metabolic risk factors, and clinical trials). It is
structured to be interactive, and includes audience response questions, case presentations,
and question and answer sessions.
EDUCATIONAL OBJECTIVES
By the end of the course, participants will be able to:
•
Distinguish memory impairment due to compromise of the medial
temporaldiencephalic memory system from frontal executive system.
•
Describe clinical circumstances where CSF examination, FDG PET, or amyloid
PET scan may be indicated.
•
Counsel patients and families on evidence-based symptomatic treatments.
•
Outline which genetic tests to order for familial AD and FTD.
•
Prescribe medications and life-style changes to reduce vascular risk.
•
Demonstrate how to refer interested persons for a clinical trial.
TARGET AUDIENCE
This course is intended for neurologists, geriatricians, primary care providers, nurses
and other health care professionals seeking to learn updates on Alzheimer disease.
Accreditation Statement
The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The Keck School of Medicine of the University of Southern California designates this live activity for a maximum of
5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP00105 for 5.75 contact hours.
REGISTRATION
22nd Annual Van Der Meulen Symposium: Dementia Update: May 16, 2015
Tuition:
Early bird registration closes May 11, 2015 at noon P.S.T.
q MD, DO: $100 q Allied Health Professionals: $75 Fellows, residents and students are complimentary.
Late registration fees apply after May 11, 2015, noon P.S.T. by telephone or fax only. Onsite registration available May 16, 2015.
q MD, DO: $125 q Allied Health Professionals: $100
Fellows, residents and students are complimentary.
Cancellation: Registration cancellations must be received by the USC Office of CME
(fax or email) by May 11, 2015, 4:00 pm P.S.T. for a refund of tuition to be issued. A $25 cancellation fee will be applied. USC will not refund any travel costs incurred. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.
Location:
Catherine and Joseph Aresty Conference Center, in the lower ground level
of the Harlyne J. Norris Cancer Research Tower on the USC Health
Sciences Campus. 1450 Biggy Street, Los Angeles, California 90033.
Parking:
Biggy Parking Structure, 1334 Biggy Street at Zonal Avenue, LA, 90033
at the Keck School of Medicine on the USC Health Sciences Campus.
Register:
Mail: 1540 Alcazar Street, CHP 223, Los Angeles, CA 90033 Online: www.usc.edu/cme, scroll down to “Van Der Meulen Symposium”
Phone: (323) 442-2555 I Fax: 1(888) 665-8650
Email: usccme@usc.edu
Onsite: Aresty Conference Center foyer
NAME______________________________________ DEGREE_____________
MEDICAL LICENSE# ______________________________________________
TELEPHONE___________________________ FAX_______________________
ADDRESS__________________________________________________________
CITY__________________________ STATE ______ ZIP CODE ___________
SPECIALTY ________________________________________________________
EMAIL ADDRESS*__________________________________________________
INSTITUTIONAL AFFILIATION ____________________________________
SPECIAL DIETARY OR PHYSICAL NEEDS____________________________
* Registration confirmation and event reminder will be emailed.
METHOD OF PAYMENT
q Check (Payable to USC) q Credit Card (Visa or Mastercard only)
Visa/Mastercard # ____________________________________________________
Expiration Date _____________Three digit security code on back of card _______
Authorized Signature __________________________ Amount $ ______________